CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-02 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +25,528 | 190,076 | ||
| 2026-04-02 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −12,472 | $34.71 | $433K | 177,604 |
| 2026-04-02 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +13,500 | 191,104 | ||
| 2026-04-02 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −6,596 | $34.71 | $229K | 184,508 |
| 2026-04-02 | Goff Brian Chief Executive Officer | Option exercise · Performance share units 10b5-1 | −25,528 | 0 | ||
| 2026-04-02 | Goff Brian Chief Executive Officer | Option exercise · Performance share units 10b5-1 | −13,500 | 40,500 | ||
| 2026-03-05 | Viswanadhan Krishnan Chief Corp Dev & Strategy | Option exercise 10b5-1 | +8,100 | 8,100 | ||
| 2026-03-05 | Viswanadhan Krishnan Chief Corp Dev & Strategy | Sale 10b5-1 | −2,959 | $27.80 | $82K | 5,141 |
| 2026-03-05 | Viswanadhan Krishnan Chief Corp Dev & Strategy | Option exercise · Restricted stock units 10b5-1 | −8,100 | 16,200 | ||
| 2026-03-03 | Washburn Theodore James Jr. Principal Accounting Officer | Sale | −5,272 | $28.88 | $152K | 868 |
| 2026-03-02 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +8,500 | 151,603 | ||
| 2026-03-02 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −3,870 | $28.96 | $112K | 147,733 |
| 2026-03-02 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +18,000 | 165,733 | ||
| 2026-03-02 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −8,267 | $28.96 | $239K | 157,466 |
| 2026-03-02 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +13,000 | 170,466 | ||
| 2026-03-02 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −5,918 | $28.96 | $171K | 164,548 |
| 2026-03-02 | Goff Brian Chief Executive Officer | Option exercise · Restricted stock units 10b5-1 | −8,500 | 0 | ||
| 2026-03-02 | Goff Brian Chief Executive Officer | Option exercise · Restricted stock units 10b5-1 | −18,000 | 18,000 | ||
| 2026-03-02 | Goff Brian Chief Executive Officer | Option exercise · Restricted stock units 10b5-1 | −13,000 | 26,000 | ||
| 2026-03-02 | Burns James William Chief Legal Officer | Option exercise 10b5-1 | +4,000 | 35,718 |
Page 5 of 48 · 941 trades